UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 845

Sortiert nach

C.04.02 What can we do to improve adherence to treatment in patients with schizophrenia?

European neuropsychopharmacology, 2013-10, Vol.23, p.S633-S633

Cañas, F

2013

Volltextzugriff (PDF)

Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: A cross-sectional study in a low cardiovascular disease risk geographical area

European psychiatry, 2009-10, Vol.24 (7), p.431-441

2009

Volltextzugriff (PDF)

C.10.01 Life-long treatment in patients with schizophrenia

European neuropsychopharmacology, 2009, Vol.19, p.S712-S713

Cañas, F

2009

Volltextzugriff (PDF)

Microbial origin of the Ordovician stromatoporoid-like organism Zondarella from the Argentine Precordillera and the post- Cambrian persistence of stromatolite microbialite reefs

Palaeogeography, palaeoclimatology, palaeoecology, 2023-10, Vol.627, p.111752, Article 111752

2023

Volltextzugriff (PDF)

C.20.02 Effective treatment of schizophrenia across the spectrum of age, severity and symptoms

European neuropsychopharmacology, 2008, Vol.18, p.S610-S611

Cañas, F

2008

Volltextzugriff (PDF)

Country differences in patient characteristics and treatment in schizophrenia: data from a physician-based survey in Europe

European psychiatry, 2011-03, Vol.26 (1), p.17-28

2011

Volltextzugriff (PDF)

C.01.03 Implications of sustained effectiveness in managing schizophrenia

European neuropsychopharmacology, 2007, Vol.17, p.S595-S596

Cañas, F

2007

Volltextzugriff (PDF)

Innovating with Concept Mapping: 7th International Conference on Concept Mapping, CMC 2016, Tallinn, Estonia, September 5-9, 2016, Proceedings

1, 2016

Volltextzugriff (PDF)

Talus fractures. Functional results for polytraumatized patients

Revista española de cirugía ortopédica y traumatología (English ed.), 2019-09, Vol.63 (5), p.336-341

2019

Volltextzugriff (PDF)

Assessing the visual quality of rural landscapes

Landscape and urban planning, 2004-07, Vol.69 (1), p.115-125

2004

Volltextzugriff (PDF)

Individualizing antipsychotic treatment selection in schizophrenia: characteristics of empirically derived patient subgroups

European psychiatry, 2011-03, Vol.26 (1), p.3-16

2011

Volltextzugriff (PDF)

The cost-effectiveness of paliperidone extended release in Spain

Journal of medical economics, 2012-11, Vol.15 (s1), p.26-34

2012

Volltextzugriff (PDF)

P.3.f.002 Epidemiologic naturalistic study to determine the relationship between the Personal and Social Performance (PSP) scale and the perceived sleep quality in schizophrenia

European neuropsychopharmacology, 2012-10, Vol.22, p.S356-S356

2012

Volltextzugriff (PDF)

PEGylated Chitosan for Nonviral Aerosol and Mucosal Delivery of the CRISPR/Cas9 System in Vitro

Molecular pharmaceutics, 2018-11, Vol.15 (11), p.4814-4826

2018

Volltextzugriff (PDF)

P.3.a.017 Do attitudes towards medication adherence in schizophrenia vary between stakeholders? A comparison of survey results

European neuropsychopharmacology, 2012-10, Vol.22, p.S313-S314

2012

Volltextzugriff (PDF)

Poster #185 THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: NURSES’ PERCEPTIONS OF THE EXTENT AND BURDEN OF PARTIAL AND NON-ADHERENCE TO MEDICATION IN PATIENTS WITH SCHIZOPHRENIA

Schizophrenia research, 2012-04, Vol.136, p.S157-S158

2012

Volltextzugriff (PDF)

Poster #186 THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: NURSES’ VIEWS ON THE TREATMENT OPTIONS FOR IMPROVING PARTIAL OR NON-ADHERENCE IN PATIENTS WITH SCHIZOPHRENIA

Schizophrenia research, 2012-04, Vol.136, p.S158-S158

2012

Volltextzugriff (PDF)

PMH33 The Cost-Effectiveness of Paliperidone ER in Spain

Value in health, 2011, Vol.14 (7), p.A292-A292

2011

Volltextzugriff (PDF)

Soluble or soluble/membrane TNF-α inhibitors protect the brain from focal ischemic injury in rats

International journal of neuroscience, 2015, Vol.125 (12), p.936-940

2015

Volltextzugriff (PDF)

Formulation of water-soluble Buddleja globosa Hope extracts and characterization of their antimicrobial properties against Pseudomonas aeruginosa

Frontiers in pharmacology, 2022-11, Vol.13, p.921511-921511

2022

Volltextzugriff (PDF)

Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial

Schizophrenia research, 2007-02, Vol.90 (1), p.147-161

2007

Volltextzugriff (PDF)

Current Status of In Vitro Models and Assays for Susceptibility Testing for Wound Biofilm Infections

Biomedicines, 2019-04, Vol.7 (2), p.34

2019

Volltextzugriff (PDF)

Soluble or soluble/membrane TNF-± inhibitors protect the brain from focal ischemic injury in rats

International journal of neuroscience, 2015-12, Vol.125 (12), p.936-940

2015

Volltextzugriff (PDF)

Intranasal immunization with dry powder vaccines

European journal of pharmaceutics and biopharmaceutics, 2018-01, Vol.122, p.167-175

2018

Volltextzugriff (PDF)

P03-275 - The EMEA ADHES survey in schizophrenia: psychiatrists’ perceptions of reasons for partial or non-adherence

European psychiatry, 2011, Vol.26, p.1444-1444

2011

Volltextzugriff (PDF)

1 – 25 von 845

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(708)
Mit Volltextzugriff
(714)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(465)
Life Sciences & Biomedicine
(320)
Humans
(238)
Female
(163)
Male
(150)
Middle Aged
(128)
Adult
(123)
Physical Sciences
(109)
Biological And Medical Sciences
(102)
Aged
(81)
Medical Sciences
(76)
Technology
(71)
Animals
(55)
Psychiatry
(47)
Astronomy & Astrophysics
(42)
Pharmacology & Pharmacy
(42)
Fundamental And Applied Biological Sciences. Psychology
(40)
Engineering
(38)
Infectious Diseases
(38)
Internal Medicine
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

C.04.02 What can we do to improve adherence to treatment in patients with schizophrenia?

Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: A cross-sectional study in a low cardiovascular disease risk geographical area

C.10.01 Life-long treatment in patients with schizophrenia

Microbial origin of the Ordovician stromatoporoid-like organism Zondarella from the Argentine Precordillera and the post- Cambrian persistence of stromatolite microbialite reefs

C.20.02 Effective treatment of schizophrenia across the spectrum of age, severity and symptoms

Country differences in patient characteristics and treatment in schizophrenia: data from a physician-based survey in Europe

C.01.03 Implications of sustained effectiveness in managing schizophrenia

Innovating with Concept Mapping: 7th International Conference on Concept Mapping, CMC 2016, Tallinn, Estonia, September 5-9, 2016, Proceedings

Talus fractures. Functional results for polytraumatized patients

Assessing the visual quality of rural landscapes

Individualizing antipsychotic treatment selection in schizophrenia: characteristics of empirically derived patient subgroups

The cost-effectiveness of paliperidone extended release in Spain

P.3.f.002 Epidemiologic naturalistic study to determine the relationship between the Personal and Social Performance (PSP) scale and the perceived sleep quality in schizophrenia

PEGylated Chitosan for Nonviral Aerosol and Mucosal Delivery of the CRISPR/Cas9 System in Vitro

P.3.a.017 Do attitudes towards medication adherence in schizophrenia vary between stakeholders? A comparison of survey results

Poster #185 THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: NURSES’ PERCEPTIONS OF THE EXTENT AND BURDEN OF PARTIAL AND NON-ADHERENCE TO MEDICATION IN PATIENTS WITH SCHIZOPHRENIA

Poster #186 THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: NURSES’ VIEWS ON THE TREATMENT OPTIONS FOR IMPROVING PARTIAL OR NON-ADHERENCE IN PATIENTS WITH SCHIZOPHRENIA

PMH33 The Cost-Effectiveness of Paliperidone ER in Spain

Soluble or soluble/membrane TNF-α inhibitors protect the brain from focal ischemic injury in rats

Formulation of water-soluble Buddleja globosa Hope extracts and characterization of their antimicrobial properties against Pseudomonas aeruginosa

Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial

Current Status of In Vitro Models and Assays for Susceptibility Testing for Wound Biofilm Infections

Soluble or soluble/membrane TNF-± inhibitors protect the brain from focal ischemic injury in rats

Intranasal immunization with dry powder vaccines

P03-275 - The EMEA ADHES survey in schizophrenia: psychiatrists’ perceptions of reasons for partial or non-adherence

Suchergebnisse filtern